phentermine has been researched along with Sleep Initiation and Maintenance Disorders in 3 studies
Phentermine: A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.
Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Importantly, the appetite suppressant-induced weight loss and locomotion were markedly reduced by intragastric (and intra-NAc shell) infusions of dopamine antagonists SCH-23390 (D1 receptor) or raclopride (D2 receptor)." | 3.81 | D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell. ( Elias, D; Gutierrez, R; Kalyanasundar, B; Luna, A; Moreno, MG; Perez, CI; Simon, SA; Solorio, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalyanasundar, B | 1 |
| Perez, CI | 1 |
| Luna, A | 1 |
| Solorio, J | 1 |
| Moreno, MG | 1 |
| Elias, D | 1 |
| Simon, SA | 1 |
| Gutierrez, R | 1 |
| Truant, AP | 1 |
| Olon, LP | 1 |
| Cobb, S | 1 |
| Lobato, DS | 1 |
| da Silveira, DD | 1 |
1 trial available for phentermine and Sleep Initiation and Maintenance Disorders
| Article | Year |
|---|---|
Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
Topics: Adult; Age Factors; Appetite Depressants; Body Weight; Clinical Trials as Topic; Constipation; Diet, | 1972 |
2 other studies available for phentermine and Sleep Initiation and Maintenance Disorders
| Article | Year |
|---|---|
D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell.
Topics: Action Potentials; Animals; Appetite Depressants; Benzazepines; Bupropion; Diethylpropion; Dopamine | 2015 |
[Clinical experience with the use of phenyltert-butylamine (phentermine) as an appetite depressant in the treatment of obesity].
Topics: Appetite Depressants; Constipation; Drug Tolerance; Headache; Humans; Obesity; Phenethylamines; Phen | 1966 |